Clinical Trial Update: Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines [Phase 4]

View source ↗

Summary

Phase 4 trial assessing immunogenicity when measles vaccine is co-administered with a Japanese encephalitis vaccine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis
• Measles
• Rubella

Drugs mentioned

• Japanese Encephalitis Vaccine (Japanese Encephalitis vaccine)
• Measles vaccine (Measles vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Measles, Rubella | Phase 4 | Status: COMPLETED